InsidersTradesSigma
Total declarations
Company
▲ Purchases (1 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
1
Disclosed sells
0
T+90 hit rate
67%
T+90 mean return
-8.7%
Across 3 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Barrett Scott, Directeur Médical. Insider active across 1 company, notably Immuneering Corp. Cumulatively, 3 disclosures have been published. Split: 1 buy · 0 sell. Total volume traded: €6k. Activity tracked since 22 March 2022. The latest transaction was filed on 22 March 2022 (Acquisition). Regulator: SEC (Form 4). All data is openly available.
Declarations3 total
900 shares@ US$7.4850.0018% mcap100.0% of flowClass A Common StockSEC:0001415889-22-003270:0
Ideal exit: 17 Dec 2022 (T+270)
5,996 sharesClass A Common StockSEC:0001104659-21-099725:0
5,996 sharesClass A Common StockSEC:0001104659-21-099725
3 of 3 declarations
About Barrett Scott
Scott Barrett is the Chief Medical Officer at Immuneering Corp. He oversees the company's medical and clinical initiatives, ensuring innovation and scientific advancement. His expertise is essential for Immuneering's success in the biopharmaceutical field.
